Clinical Trials Logo

Citation(s)

sCD163 & CD19 as Candidate Biomarkers in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - A Study of sCD163 in the Cerebrospinal Fluid

Details for clinical trial NCT02271724